Larvol Delta - Cellectar-Enrolls-First-Patient-in-CLR-125-AugerEmitting-Radioconjugate-Phase-1b-Clinical-Trial-Targeting-Refractory-Triple-Negative-Breast-Cancer-TNBC

CLR-121125 - Cellectar

https://www.globenewswire.com/news-release/2026/04/14/3273404/29076/en/Cellectar-Enrolls-First-Patient-in-CLR-125-Auger-Emitting-Radioconjugate-Phase-1b-Clinical-Trial-Targeting-Refractory-Triple-Negative-Breast-Cancer-TNBC.html

Apr 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next